PolyNovo |
High $1.56 |
Low $1.52 |
Trades 1,747 |
Turnover $1,891,056 |
Volume 1,225,647 |
| 30 June 2023 at 4:10pm | ||||
|
Market Cap (13-Nov) $618,303,552 (311th) |
Close (30-Jun) $1.55 |
Volume (30-Jun) 1,225,647 |
Shortsold (6-Nov) 46,180,514 (6.68%) (49th) |
|
52w High $1.30 |
52w Low $0.81 |
P/E 90.91 |
EPS 0.01 |
[ARTICLE] Regal’s Phil King was right on Polynovo ... eventually
A news article has been posted about PolyNovo on the AFR. The article was published around , on 17 November 2021 at 6:13pm.
Still, given we did highlight the fact that Polynovo had soared to new heights shortly after being named as Phil King ’s top short idea at the 2019 Sohn Hearts & Minds conference, suppose we can do Regal Funds Management the courtesy of noting the hedge fund has enjoyed some vindication of late.
Read ArticlePNV was $1.51 at the close of trade on 17 November 2021
| Recent Articles about ASX:PNV | |
|---|---|
| 11-Nov | PNV:ASX Announcement - Final Director's Interest Notice - Dr Elliott
company-announcements.afr.com |
| 1-Nov | RTF Template - AFR
company-announcements.afr.com |
| 30-Oct | Results of 2026 Annual General Meeting - AFR
company-announcements.afr.com |
| 30-Oct | $150m $13.4m 3 years - AFR
company-announcements.afr.com |
| 26-Oct | Correction to Notice of Meeting for 2026 AGM - Market Index
company-announcements.afr.com |
| 20-Oct | CFO Jan Gielen to depart PolyNovo and take up new opportunity
company-announcements.afr.com |
| 8-Oct | 28 September 2026 - AFR
company-announcements.afr.com |
| 23-Sep | Cadence Capital Limited ANNUAL REPORT 2026 - AFR
company-announcements.afr.com |
| 22-Sep | ASX Announcement Australian Clinical Labs Limited Tuesday ... - AFR
company-announcements.afr.com |
| 22-Sep | Australian Clinical Labs Limited - 2026 Annual General Meeting - AFR
company-announcements.afr.com |
| Tracked |
Find all articles about PolyNovo, including others on the AFR, on the media page.
If you were already registered, log in here.